Search Within

Maria C Pietanza

Formats
  1. Meeting Abstract (67)
  2. Journal Article (50)
  3. Book Section (4)
  4. Correspondence (1)
Groups
  1. Department of Medicine (84)
  2. Solid Tumor Oncology Division (81)
  3. Thoracic Oncology (75)
  4. Department of Pathology and Laboratory Medicine (50)
  5. GSK Faculty (48)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)

More Groups

People
  1. Mark Kris (50)
  2. Lee Krug (37)
  3. Charles Rudin (33)
  4. William Travis (33)
  5. Gregory Riely (27)
  6. Natasha Rekhtman (24)

More People

Years
  1. 2019 (2)
  2. 2018 (2)
  3. 2017 (8)
  4. 2016 (16)
  5. 2015 (24)
  6. 2014 (15)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Journal of Thoracic Oncology (26)
  3. Modern Pathology (8)
  4. International Journal of Radiation Oncology, Biology, Physics (6)
  5. Laboratory Investigation (6)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (39)
  2. American Society of Clinical Oncology (29)
  3. Nature Publishing Group (8)
  4. Nature Research (8)
  5. Oxford University Press (6)
  6. American Association for Cancer Research (5)

More Publishers

Results (122)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-grade neuroendocrine transformation of post-treatment conventional breast carcinoma
    Meeting Abstract

    Weisman, P.; Rekhtman, N.; Corben, A.; Dickler, M.; Pietanza, M.; Tan, L.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • High-grade neuroendocrine transformation of post-treatment conventional breast carcinoma
    Meeting Abstract

    Weisman, P.; Rekhtman, N.; Corben, A.; Dickler, M.; Pietanza, M.; Tan, L.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Prognostic value of SUV and non-SUV PET metrics in pre-chemoradiotherapy patients in limited-stage small cell lung cancer
    Meeting Abstract

    Ong, L.; Wu, A.; Foster, A.; Perez, C.; Pietanza, M.; Rosenzweig, K.; Gelblum, D.; Rimner, A.; Dunphy, M.
    Journal of Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • Phase 1b of anticancer stem cell antibody OMP-59R5 (anti-Notch2/3) in combination with etoposide and cisplatin (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)
    Meeting Abstract

    Spigel, D. R.; Spira, A. I.; Jotte, R. M.; Gadgeel, S. M.; Mita, A. C.; Hart, L. L.; Kapoun, A.; Xu, L.; Hill, D.; Zhou, L.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Pietanza, M. C.; Krug, L. M.; Varghese, A. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A.; Sima, C. S.; Litvak, A. M.; Ng, K. K.; Patel, P. R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Stage IV large cell neuroendocrine carcinoma (LCNEC) of the lung: Clinicopathologic features, treatment, and survival
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Rekhtman, N.; Thomas, S. B.; Sarkaria, I. S.; Rudin, C. M.; Krug, L. M.; Pietanza, M. C.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase 1B trial of anti-notch 2/3 antibody OMP-59R5 in combination with etoposide and cisplatin (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC): The pinnacle study
    Meeting Abstract

    Pietanza, M. C.; Spira, A.; Jotte, R.; Gadgeel, S.; Mita, A.; Liu, S.; Gluck, W. L.; Kalemkerian, G. P.; Chiang, A.; Hart, L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes for 61 patients with metastatic pulmonary carcinoids
    Meeting Abstract

    Litvak, A.; Iyriboz, T.; Zakowski, M.; Woo, K.; Krug, L.; Rudin, C.; Pietanza, M.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis program (MAP) at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Krug, L. M.; Pietanza, M. C.; Varghese, A. M.; Won, H.; Wang, L.; Rekhtman, N.; Travis, W. D.; Litvak, A.; Paik, P. K.; Riely, G. J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Should all limited-stage small cell lung cancer be treated alike?: Impact of AJCC stage on brain metastasis, survival, and patterns of failure
    Meeting Abstract

    Wu, A. J.; Gillis, A.; Foster, A.; Woo, K.; Zhang, Z.; Gelblum, D. Y.; Downey, R. J.; Rosenzweig, K. E.; Ong, L.; Perez, C. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save